Patrick J Mcenany - Net Worth and Insider Trading

Patrick J Mcenany Net Worth

The estimated net worth of Patrick J Mcenany is at least $99 Million dollars as of 2024-11-10. Patrick J Mcenany is the President and CEO of Catalyst Pharmaceuticals Inc and owns about 4,119,285 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $99 Million. Patrick J Mcenany is also the Director of ThermoGenesis Holdings Inc and owns about 3 shares of ThermoGenesis Holdings Inc (THMO) stock worth over $0. Details can be seen in Patrick J Mcenany's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick J Mcenany has not made any transactions after 2023-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Patrick J Mcenany

To

Patrick J Mcenany Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick J Mcenany owns 2 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) , and ThermoGenesis Holdings Inc (THMO) .

Click here to see the complete history of Patrick J Mcenany’s form 4 insider trades.

Insider Ownership Summary of Patrick J Mcenany

Ticker Comapny Transaction Date Type of Owner
CPRX Catalyst Pharmaceuticals Inc 2023-05-15 director & 10 percent owner & President and Chief Executive
THMO ThermoGenesis Holdings Inc 2009-05-19 director

Patrick J Mcenany Latest Holdings Summary

Patrick J Mcenany currently owns a total of 2 stocks. Among these stocks, Patrick J Mcenany owns 4,119,285 shares of Catalyst Pharmaceuticals Inc (CPRX) as of May 15, 2023, with a value of $99 Million and a weighting of 100%. Patrick J Mcenany also owns 3 shares of ThermoGenesis Holdings Inc (THMO) as of May 19, 2009, with a value of $0 and a weighting of 0%.

Latest Holdings of Patrick J Mcenany

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPRX Catalyst Pharmaceuticals Inc 2023-05-15 4,119,285 23.93 98,574,490
THMO ThermoGenesis Holdings Inc 2009-05-19 3 0.00 0

Holding Weightings of Patrick J Mcenany


Patrick J Mcenany Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick J Mcenany has made a total of 7 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 26,151 shares on May 15, 2023, which brought Patrick J Mcenany around $345,978.

According to the SEC Form 4 filings, Patrick J Mcenany has made a total of 0 transactions in ThermoGenesis Holdings Inc (THMO) over the past 5 years. The most-recent trade in ThermoGenesis Holdings Inc is the acquisition of 1 shares on May 19, 2009, which cost Patrick J Mcenany around $14,500.

Insider Trading History of Patrick J Mcenany

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick J Mcenany Trading Performance

GuruFocus tracks the stock performance after each of Patrick J Mcenany's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Mcenany is 36.79%. GuruFocus also compares Patrick J Mcenany's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Mcenany within 3 months outperforms 21 times out of 29 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick J Mcenany's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick J Mcenany

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
21 out of 29 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.27 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 14.26 LIMIT LIMIT LIMIT LIMIT LIMIT

Patrick J Mcenany Ownership Network

Ownership Network List of Patrick J Mcenany

No Data

Ownership Network Relation of Patrick J Mcenany

Insider Network Chart

Patrick J Mcenany Owned Company Details

What does Catalyst Pharmaceuticals Inc do?

Who are the key executives at Catalyst Pharmaceuticals Inc?

Patrick J Mcenany is the director & 10 percent owner & President and Chief Executive of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .

Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary

Over the past 18 months, Patrick J Mcenany made 1 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 26,151. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .

In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.

Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Catalyst Pharmaceuticals Inc Insider Transactions

No Available Data

Patrick J Mcenany Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick J Mcenany. You might contact Patrick J Mcenany via mailing address: C/o Thermogenesis Corp, 2711 Citrus Road, Rancho Cordova Ca 95742.